Conditions: Asthma
Keywords: Moderate Asthma Severe Asthma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 742
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the effectiveness and safety of SYMBICORT® pMDI (a medication approved by the Food and Drug Administration, FDA) in the African American population.

Detailed description:

Arms:
arm 1: Symbicort pMDI 160/4.5 ug x 2 actuations twice daily (BID) arm 2: Budesonide HFA pMDI 160 ug x 2 actuations BID

Interventions: intervention 1: Budesonide/formoterol (SYMBICORT) pMDI intervention 2: Budesonide HFA pMDI
Intervention descriptions: intervention 1: Symbicort pMDI 160/4.5 ug x 2 actuations twice daily (BID) intervention 2: Budesonide HFA pMDI 160 ug x 2 actuations BID

Protocol document: